ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $783,069 | -31.5% | 261,023 | -14.6% | 0.00% | – |
| Q2 2023 | $1,143,397 | +21.9% | 305,721 | +9.2% | 0.00% | – |
| Q1 2023 | $938,201 | -19.8% | 280,060 | +15.1% | 0.00% | – |
| Q4 2022 | $1,169,874 | -14.5% | 243,217 | +1.2% | 0.00% | – |
| Q3 2022 | $1,368,000 | -15.2% | 240,384 | +5.8% | 0.00% | – |
| Q2 2022 | $1,613,000 | +10.8% | 227,220 | +12.7% | 0.00% | – |
| Q1 2022 | $1,456,000 | -41.7% | 201,693 | -27.9% | 0.00% | – |
| Q4 2021 | $2,499,000 | -90.0% | 279,568 | -60.8% | 0.00% | -100.0% |
| Q3 2021 | $25,006,000 | +206.2% | 713,225 | +87.6% | 0.01% | +150.0% |
| Q2 2021 | $8,167,000 | -48.0% | 380,224 | +49.6% | 0.00% | -50.0% |
| Q1 2021 | $15,696,000 | +54.2% | 254,188 | +4.3% | 0.00% | +33.3% |
| Q4 2020 | $10,179,000 | – | 243,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |